Ratings by Morgan Stanley (Michael E Ulz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Downgrade | Underweight (Equalweight) |
6.59 (4.96) |
-24.73% | Details | |
| 5/5/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2026 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/27/2026 | Rocket Pharmaceuticals | RCKT | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/26/2026 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/5/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Aardvark Therapeutics Inc | AARD | Downgrade | Equalweight (Overweight) |
12.50 (6.59) |
-47.28% | Details | |
| 3/2/2026 | Aardvark Therapeutics Inc | AARD | Downgrade | Equalweight (Overweight) |
12.50 (12.50) |
0% | Details | |
| 2/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2026 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2026 | Fractyl Health Inc | GUTS | Downgrade | Equalweight (Overweight) |
1.83 (0.78) |
-57.38% | Details | |
| 1/8/2026 | IO Biotech | IOBT | Downgrade | Underweight (Equalweight) |
0.64 (0.05) |
-92.19% | Details | |
| 12/8/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2025 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2025 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2025 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 9/30/2025 | IO Biotech | IOBT | Downgrade | Equalweight (Overweight) |
1.58 (0.05) |
-96.84% | Details | |
| 8/19/2025 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | IO Biotech | IOBT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2025 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/24/2025 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/25/2025 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2025 | Rocket Pharmaceuticals | RCKT | Downgrade | Equalweight (Overweight) |
6.27 (3.30) |
-47.37% | Details | |
| 5/27/2025 | Rocket Pharmaceuticals | RCKT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2025 | Aardvark Therapeutics Inc | AARD | New Coverage | Overweight (N/A) |
9.52 (12.50) |
31.3% | Details | |
| 2/27/2025 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/7/2025 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/3/2025 | Fractyl Health Inc | GUTS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/30/2024 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2024 | Rocket Pharmaceuticals | RCKT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2024 | Viking Therapeutic | VKTX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/9/2024 | IO Biotech | IOBT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/3/2024 | IO Biotech | IOBT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2024 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2024 | Arrowhead Pharma | ARWR | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/27/2024 | Viking Therapeutic | VKTX | New Coverage | Overweight (N/A) |
47.80 (37.87) |
-20.77% | Details | |
| 6/17/2024 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 5/21/2024 | Dyne Therapeutics | DYN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2024 | Arrowhead Pharma | ARWR | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/10/2024 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2024 | Dyne Therapeutics | DYN | New Coverage | Overweight (N/A) |
24.73 (20.33) |
-17.79% | Details | |
| 2/27/2024 | Fractyl Health Inc | GUTS | New Coverage | Overweight (N/A) |
8.33 (1.83) |
-78.03% | Details | |
| 2/7/2024 | Arrowhead Pharma | ARWR | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/29/2023 | Arrowhead Pharma | ARWR | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/13/2023 | Mirum Pharamceuticals | MIRM | New Coverage | Overweight (N/A) |
28.48 (114.97) |
303.69% | Details | |
| 5/3/2023 | Arrowhead Pharma | ARWR | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/1/2023 | Rocket Pharmaceuticals | RCKT | New Coverage | Overweight (N/A) |
21.22 (6.27) |
-70.45% | Details |
